» Articles » PMID: 36628881

Immune Infiltration Patterns and Identification of New Diagnostic Biomarkers GDF10, NCKAP5, and RTKN2 in Non-small Cell Lung Cancer

Overview
Journal Transl Oncol
Specialty Oncology
Date 2023 Jan 11
PMID 36628881
Authors
Affiliations
Soon will be listed here.
Abstract

This study aimed to identify potential biomarkers for non-small cell lung cancer (NSCLC) and analyze the role of immune cell infiltration in NSCLC. R software was used to screen differentially expressed genes (DEGs) from NSCLC datasets obtained from the Gene Expression Omnibus (GEO) database, and functional correlation analysis was performed. The machine learning algorithms were used to screen the potential biomarkers of NSCLC. The diagnostic values were assessed through receiver operating characteristic (ROC) curves. The protein and mRNA expression levels of potential biomarkers were verified based on the Human Protein Atlas (HPA) database and qRT-PCR. CIBERSORT was used to evaluate the infiltration of immune cells in NSCLC tissues, and the correlation between potential biomarkers and infiltrated immune cell was analyzed. Finally, specific siRNAs were utilized to reduce the GDF10, NCKAP5, and RTKN2 expression in A549 and H1975 cells. The proliferation ability of A549 and H1975 cells was detected by MTT assay. A total of 848 upregulated DEGs and 1308 downregulated DEGs were identified. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses showed that the DEGs were mainly related to cell division. Disease ontology (DO) enrichment analysis showed that the diseases with these DEGs were mainly lung diseases, including NSCLC. In addition,three potential biomarkers were identified: GDF10, NCKAP5, and RTKN2. Immune cell infiltration analysis showed that resting NK cells, activated dendritic cells, and Tregs may be involved in the pathogenesis of NSCLC. Meanwhile, GDF10, NCKAP5, and RTKN2 were negatively correlated with Tregs and naïve B cells but were positively correlated with activated dendritic cells and resting NK cells. Immunohistochemical staining showed that the expression of GDF10, NCKAP5, and RTKN2 in the lung tissue of patients with NSCLC was lower than that of normal lung tissue. qRT-PCR also confirmed that the mRNA expression of three biomarkers in NSCLC cell lines A549 and H1975 were significantly lower than those in human normal lung epithelial cells BEAS-2B. An MTT assay showed that GDF10, NCKAP5, and RTKN2 knockdown significantly promoted the proliferation of A549 and H1975 cells. The in vitro experiments showed that GDF10, NCKAP5, and RTKN2 played the inhibitory effects on NSCLC cell lines proliferation. Hence, GDF10, NCKAP5, and RTKN2 can be used as diagnostic biomarkers for NSCLC.

Citing Articles

Identification of potential biomarkers for lung cancer using integrated bioinformatics and machine learning approaches.

Rabby M, Islam M, Kumar S, Maniruzzaman M, Hasan M, Tomioka Y PLoS One. 2025; 20(2):e0317296.

PMID: 40014586 PMC: 11867339. DOI: 10.1371/journal.pone.0317296.


Candidate SNP Markers Significantly Altering the Affinity of the TATA-Binding Protein for the Promoters of Human Genes Associated with Primary Open-Angle Glaucoma.

Zolotareva K, Dotsenko P, Podkolodnyy N, Ivanov R, Makarova A, Chadaeva I Int J Mol Sci. 2024; 25(23).

PMID: 39684516 PMC: 11641052. DOI: 10.3390/ijms252312802.


Radial Data Visualization-Based Step-by-Step Eliminative Algorithm to Predict Colorectal Cancer Patients' Response to FOLFOX Therapy.

Kryczka J, Bachorz R, Kryczka J, Boncela J Int J Mol Sci. 2024; 25(22).

PMID: 39596218 PMC: 11595261. DOI: 10.3390/ijms252212149.


Prognostic and onco-immunological value of immune-related eRNAs-driven genes in lung adenocarcinoma.

Wu X, Zhao X, Zhou C, Wei N, Xu Z, Zhang X J Cancer Res Clin Oncol. 2024; 150(4):188.

PMID: 38602568 PMC: 11008071. DOI: 10.1007/s00432-024-05687-5.


Crosstalk between lncRNAs and Wnt/β-catenin signaling pathways in lung cancers: From cancer progression to therapeutic response.

Wu T, Dong Y, Yang X, Mo L, You Y Noncoding RNA Res. 2024; 9(3):667-677.

PMID: 38577016 PMC: 10987302. DOI: 10.1016/j.ncrna.2024.02.013.